SASSINE ANDY 4
4 · Arcturus Therapeutics Holdings Inc. · Filed Aug 19, 2025
Insider Transaction Report
Form 4
SASSINE ANDY
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock
2025-08-15$16.56/sh−1,238$20,499→ 221,764 total
Footnotes (2)
- [F1]The purchase reported on this Form 4 was effected by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the "ESPP").
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025.